Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Plus Therapeutics Inc (NQ: PSTV )

0.5103 -0.0298 (-5.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,408
Open 0.5323
Bid (Size) 0.5103 (10)
Ask (Size) 0.5500 (352)
Prev. Close 0.5401
Today's Range 0.5075 - 0.5323
52wk Range 0.4102 - 2.600
Shares Outstanding 22,197,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Plus Therapeutics Concludes Enrolment In Initial-Stage Study Of Cerebrospinal Fluid Cancer Setting
Plus Therapeutics (NASDAQ: PSTV) has concluded patient enrolment in the first cohort of the ReSPECT-LM Phase 1/2a dose escalation clinical trial of Rhenium-186 NanoLiposome (186RNL) for the treatment... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-53.22%
-53.22%
1 Month
-24.91%
-24.91%
3 Month
-49.97%
-49.97%
6 Month
-53.22%
-53.22%
1 Year
-78.65%
-78.65%

More News

Read More
83 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
Plus Therapeutics: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
3 Stocks Under $1 Insiders Are Aggressively Buying
Via Benzinga
3 Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
55 Biggest Movers From Friday
Via Benzinga
Earnings Preview For Plus Therapeutics
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Via Benzinga
Earnings Scheduled For April 21, 2022
Via Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Recap: Plus Therapeutics Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of Goldman Sachs Earnings
Via Benzinga
5 Stocks To Watch For January 18, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.